AU
UK
CA
NZ
IND
US
Stock Market Reaction: Liquidity Relief Drives the Rally
Rocket Pharmaceuticals (NASDAQ: RCKT)emerged as a key outperformer after announcing US Food and Drug Administration accelerated approval for KRESLADI, a gene therapy targeting pediatric patients with severe leukocyte adhesion deficiency-I. The approval represents a pivotal inflection point for the company’s rare disease franchise. Importantly, …
Introduction: FDA Approval Drives Strategic Milestone for Denali
The US sector rotation on 27 March 2026, reveals a highly unusual and skewed momentum environment. As the momentum chart illustrates, capital is not broadening out; it is funneling aggressively into one specific theme, leaving a growing portion of the market struggling in the …
The US equity market on March 27, 2026, experienced a pronounced "risk-off" session, characterized by a sharp sell-off in economically sensitive cyclical sectors and high-valuation growth names. Capital aggressively sought shelter in hard assets and reliable, low-beta dividend payers, signaling elevated anxiety regarding the …
Please wait processing your request...